毕得医药(688073.SH)总经理戴岚拟减持不超0.16%股份

Core Viewpoint - Bid Pharma (688073.SH) announced a plan for its controlling shareholder and actual controller, Dai Lan, to reduce his shareholding in the company due to personal funding needs [1] Group 1 - The reduction plan will be executed through centralized bidding transactions within three months after the disclosure of the reduction plan, starting from 15 trading days thereafter [1] - The maximum number of shares to be reduced is 148,800 shares, which accounts for no more than 0.16% of the company's total share capital [1] - The reduction price will be determined based on the market price at the time of the actual implementation [1]